Nanopore sequencing has emerged as a transformative approach in genomics, enabling scientists to decode DNA and RNA molecules in real-time with unprecedented portability. Unlike traditional sequencing methods that require extensive sample preparation and batch processing, nanopore technology generates long reads and delivers results within minutes of starting a run. This capability has proven especially powerful for genomic surveillance—the continuous monitoring of pathogen genomes to track transmission, detect mutations, and inform public health responses. During recent outbreaks of Ebola, Zika, and COVID-19, nanopore sequencing has been deployed in field settings and reference laboratories alike, demonstrating its utility as a frontline tool for real-time outbreak management.

How Nanopore Sequencing Works

Nanopore sequencing relies on a simple but elegant principle: a single molecule of DNA or RNA is passed through a nanometer-scale pore embedded in a synthetic membrane. As the molecule translocates through the pore, it disrupts an ionic current flowing across the membrane. The magnitude and duration of these current changes are specific to each nucleotide—or group of nucleotides—allowing the sequence to be determined in real-time. This direct, electrical detection method eliminates the need for enzymatic amplification (such as PCR) or fluorescent labeling, which are required by other sequencing platforms. The entire process is monitored by a proprietary application-specific integrated circuit (ASIC) that measures current changes at thousands of pores simultaneously, enabling high-throughput sequencing from a single device.

Key to the technology's portability is the flow cell—a consumable that contains the nanopores and microfluidics. Devices like the MinION (small enough to fit in a pocket) and the higher-throughput GridION are designed for field deployment, while the PromethION series offers even greater capacity for large-scale surveillance projects. Because the platform can sequence DNA directly or via RNA (using direct RNA sequencing), it provides a versatile solution for genotyping whole genomes, identifying structural variants, and detecting epigenetic modifications without additional chemical conversion steps.

Key Advantages for Genomic Surveillance

Nanopore sequencing offers several distinct benefits that make it particularly suited for real-time genomic surveillance:

  • Real-time data streaming: Data is analyzed as soon as a molecule passes through a pore, allowing researchers to see preliminary results within minutes of starting a run. This enables rapid decision-making during outbreaks, such as identifying the pathogen's species or key mutations before the full genome is assembled.
  • Long read lengths: Nanopore sequencing routinely produces reads tens to hundreds of kilobases in length. Long reads are critical for resolving repetitive regions in viral and bacterial genomes, detecting large structural variants, and assembling complete genomes without the gaps common in short-read assemblies.
  • Portability and low power consumption: The MinION connects to a laptop via USB, runs on battery power, and weighs only 100 grams. This makes it deployable in remote clinics, airports, mobile laboratories, or even on the International Space Station, enabling surveillance in locations where traditional sequencing infrastructure is unavailable.
  • Cost-effectiveness: The initial capital investment for a MinION is a fraction of that required for high-throughput Illumina systems. Consumables—flow cells and sequencing kits—are relatively inexpensive, and the lack of a need for expensive library preparation instruments reduces overall operational costs for small labs and outbreak response teams.
  • Direct RNA sequencing: The ability to sequence RNA directly (without reverse transcription and amplification) preserves base modifications such as N6-methyladenosine, which can be important for understanding viral replication and host-pathogen interactions. This feature is increasingly used in surveillance of RNA viruses like SARS-CoV-2 and influenza.

Comparison with Other Sequencing Technologies

To understand the niche occupied by nanopore sequencing, it is helpful to compare it with the dominant short-read platforms (e.g., Illumina) and other long-read options (e.g., PacBio). Illumina sequencing offers very high accuracy (99.9% base-level accuracy) and high throughput at low cost per base, but it produces reads of only 150–300 bases. This limits its ability to resolve repetitive regions, phase haplotypes, and detect large structural variants. PacBio's HiFi reads combine long reads with high accuracy (similar to Illumina) but require larger capital investment and are less portable. Nanopore sequencing, while historically criticized for higher error rates (~5-15% per read initially), has improved dramatically with updates to pore chemistry, basecalling algorithms, and consensus methods. With the latest R10.4 flow cells and high-accuracy basecalling models, consensus accuracies can exceed 99.9% for bacterial genomes and >99% for viral genomes. The trade-off is that single-molecule accuracy remains lower than short reads, but the long read length and real-time output compensate in many surveillance applications.

Case Studies: Real-time Outbreak Response

Ebola Virus (2014–2016 West Africa Outbreak)

One of the earliest large-scale deployments of nanopore sequencing for outbreak surveillance occurred during the Ebola epidemic in West Africa. Researchers used the MinION to sequence Ebola virus genomes from patient samples in Guinea and Sierra Leone. The rapid turnaround—from sample collection to genome analysis in under 24 hours—allowed epidemiologists to trace transmission chains and identify whether the virus was evolving in ways that could affect diagnostics, treatments, or vaccines. A landmark study published in Nature demonstrated that real-time nanopore sequencing provided actionable data for outbreak control, despite the challenging field conditions (see Quick et al., Nature, 2016).

Zika Virus (2015–2016 Epidemic)

During the Zika epidemic in the Americas, nanopore sequencing was used to rapidly generate whole-genome sequences from mosquito vectors and human patients. The ability to sequence directly from low-titer samples without extensive amplification helped researchers track the spread of the virus across continents and monitor for mutations that might be associated with increased virulence or transmissibility. The portable nature of the MinION was especially valuable in resource-limited settings where central laboratory infrastructure was scarce.

COVID-19 Pandemic

The global SARS-CoV-2 pandemic accelerated the adoption of nanopore sequencing for genomic surveillance. The ARTIC Network (a collaboration led by the Wellcome Sanger Institute and partners) developed an amplicon-based protocol for sequencing the entire ~30 kb SARS-CoV-2 genome on the MinION and GridION platforms. This protocol became one of the most widely used methods globally, contributing to the millions of SARS-CoV-2 sequences deposited in public databases. The real-time data streaming allowed public health laboratories to quickly identify variants of concern (e.g., Alpha, Delta, Omicron) and track their emergence and spread. Countries such as the United Kingdom, South Africa, and Brazil relied heavily on nanopore sequencing to inform lockdown measures, travel restrictions, and vaccine deployment strategies. A review of genomic surveillance efforts notes that nanopore sequencing was instrumental in providing rapid genomic data in both high- and low-income settings (see Gardy and Loman, Nature Reviews Genetics, 2022).

Challenges and Current Limitations

Despite its impressive capabilities, nanopore sequencing is not without limitations that must be acknowledged for responsible surveillance:

  • Single-read error rates: Even with recent improvements, raw read accuracy is lower than that of short-read platforms. This is particularly problematic for detecting low-frequency variants, such as early stages of drug resistance or quasispecies in viral populations. Consensus approaches (building a single consensus sequence from many reads) mitigate this, but sub-consensus variants require careful variant calling with specialized tools (e.g., Medaka, Clair3, Nanopolish).
  • Basecalling latency: While data streams in real-time, the conversion of electrical signals to bases (basecalling) requires computational resources. Real-time basecalling on the device's GPU has improved, but high-accuracy models (e.g., "super accurate" mode) can still introduce delays of minutes to hours, depending on throughput.
  • Sample quality and bias: Successful nanopore sequencing requires high-molecular-weight DNA or intact RNA. Degraded samples, common in field settings, can lead to shorter reads and reduced data yield. Additionally, amplification steps used in some protocols (e.g., ARTIC amplicon schemes) can introduce PCR bias and limit the detection of unexpected genomic rearrangements.
  • Cost per genome for large-scale studies: While the initial investment is low, the per-genome cost can be higher than Illumina for very large projects (thousands of genomes) due to the cost of flow cells and the lower throughput per run. For surveillance programs requiring rapid turnaround on a moderate number of samples (10–100 per week), nanopore sequencing is highly competitive, but for population-scale sequencing of tens of thousands of samples, short-read platforms still dominate.
  • Standardization and reproducibility: The rapid evolution of pore chemistries, basecalling algorithms, and library preparation kits means that protocols change frequently. This can challenge the reproducibility of results over time and between laboratories. The field is working toward standardized best practices, such as those published by the Consortium for Nanopore Sequencing.

Emerging Innovations and Future Directions

The nanopore sequencing landscape continues to evolve rapidly. Several key areas of development promise to further enhance its role in genomic surveillance:

Improved Accuracy and Error Correction

New protein nanopores (e.g., R10.4 and R10.5) have been engineered to resolve bases more accurately, especially in homopolymer regions (e.g., AAAA) that historically caused high error rates. Combined with deep learning basecallers (e.g., Bonito, Dorado), raw read accuracy now routinely exceeds 98% for Q20+ consensus. Error correction methods that incorporate short-read data or use consensus from multiple molecules are also being automated, making high-quality genomes obtainable from nanopore-only data.

Real-time Metagenomics and Pathogen Discovery

Beyond targeted surveillance of known pathogens, nanopore sequencing is being applied to untargeted metagenomics—sequencing all nucleic acids in a clinical or environmental sample. Real-time streaming allows "live" classification of reads against reference databases (e.g., using EPI2ME, a cloud-based analysis platform). This can identify emerging pathogens, such as novel influenza strains or antimicrobial resistance genes, within minutes of a run starting. For example, the WHO has highlighted the potential of nanopore metagenomics for early detection of disease X—a hypothetical unknown pathogen that could cause a future pandemic.

Direct Detection of Methylation and Epigenetic Modifications

Nanopore sequencing detects not only bases but also base modifications because modified nucleotides alter the ionic current signal in characteristic ways. This allows direct detection of DNA methylation (e.g., 5-methylcytosine, 6-methyladenine) and RNA modifications without additional chemical treatment. In surveillance, this could help monitor changes in viral modification patterns that might affect host immune evasion or replication kinetics.

Integrated Portable Labs

Several initiatives are developing fully portable, solar-powered sequencing rigs that combine a MinION with a laptop, a small centrifuge, and a portable PCR thermocycler (or isothermal amplification device). These "lab-in-a-backpack" setups are being tested in remote regions of Africa, South America, and Southeast Asia for real-time surveillance of diseases such as Lassa fever, dengue, and yellow fever. The goal is to achieve a sample-to-result time of less than six hours, including library preparation and basecalling.

Practical Considerations for Implementing Nanopore Surveillance

For public health agencies and laboratories considering adopting nanopore sequencing for genomic surveillance, several strategic factors are worth weighing:

  • Throughput requirements: Assess the number of samples to be processed per week. The MinION can run one flow cell at a time, with throughput typically ranging from 10 to 50 Gb per run (depending on read length and pore occupancy). For higher throughput, the GridION (five flow cells) or PromethION (24 or 48 flow cells) are more appropriate.
  • Bioinformatics infrastructure: While the manufacturer provides user-friendly software (MinKNOW, EPI2ME), more advanced analysis (de novo assembly, variant calling, phylogenetic analysis) requires familiarity with command-line tools or cloud-based platforms. Training programs and community resources (such as the ARTIC field bioinformatics pipelines) help lower the barrier.
  • Quality control: Establishing internal controls (e.g., spike-in standards, negative controls) is critical to monitor for contamination and assess sequencing performance. Many successful surveillance programs use a combination of nanopore and confirmatory short-read sequencing for critical samples.
  • Data sharing and interoperability: Real-time genomic surveillance is most powerful when sequences are shared quickly via public repositories (GISAID, GenBank, ENA). Nanopore-specific metadata (e.g., pore version, basecaller version) should be reported to facilitate reproducibility.

Conclusion

Nanopore sequencing has fundamentally altered the practice of genomic surveillance by providing a real-time, portable, and increasingly accurate method for decoding pathogen genomes. Its successful deployment during Ebola, Zika, and COVID-19 outbreaks demonstrates its value for rapid detection and monitoring of infectious threats. While challenges such as error rates, standardization, and cost for very large projects remain, ongoing improvements in pore engineering, basecalling algorithms, and integrated portable systems are steadily overcoming these barriers. As the technology matures, nanopore sequencing is poised to become a standard tool in the global surveillance toolkit—enabling faster, more equitable responses to emerging infectious diseases and ultimately strengthening pandemic preparedness worldwide.